Advertisement

Osteoporosis International

, Volume 28, Issue 8, pp 2299–2307 | Cite as

The association between serum uric acid level and the risk of fractures: a systematic review and meta-analysis

  • P. Yin
  • H. Lv
  • Y. Li
  • Y. Meng
  • L. ZhangEmail author
  • P. TangEmail author
Review

Abstract

Controversy has arisen in regarding the association between serum uric acid (UA) and fracture risk. Therefore, we conducted a systemic review and meta-analysis by pooling estimate of five prospective studies (29,110 participants). Results showed that an increased serum UA level is associated with a lower risk of fracture. Numerous studies have demonstrated that high serum UA is a relevant risk factor for a wide variety of diseases, whereas new understanding in serum uric acid follows recent reports demonstrating a protective role of UA in health status. However, the association between serum UA and fracture remains controversial. Therefore, we conduct a systemic review and meta-analysis to determine whether elevated UA level is a protective factor for fracture among prospective studies. We searched for studies published before May 6, 2016, using PubMed, Embase, and Cochrane databases, without any language restriction. The inclusion criteria were published studies investigating the association between UA and fractures. Two authors independently screened the retrieved articles in accordance to the predefined inclusion criteria. We pooled the study-specific relative risk estimates using a random-effect model for comparison of persons whose UA levels were in the top tertile with those in the bottom tertile. Factors that may predict these associations were evaluated in subgroup analysis and meta-regression. The five included prospective studies included 29,110 participants. In random-effect models that included all five included studies, the summary hazard ratios (HRs) (top vs bottom tertiles) were 079 (95% CI, 0.69 to 0.89), without evidence of heterogeneity (P for heterogeneity = 0.458; I 2 = 0%). Similar results were shown when pooling estimate of three higher-quality studies (HR 0.80 95% CI, 0.69 to 0.93). The association between UA and fracture remained in sensitivity and subgroup analyses. An increased serum UA level is shown to be associated with a lower risk of fracture, albeit additional large, high-quality prospective studies or a meta-analysis of individual data are still needed to verify the association.

Keywords

Fracture Gout Meta-analysis Uric acid 

Notes

Acknowledgements

We thank Prof. Fernando Rivadeneira and his postdoctoral researcher Taulant Muka for providing the information concerning their original study which was included in our study.

Compliance with ethical standards

Conflicts of interest

None.

Supplementary material

198_2017_4059_MOESM1_ESM.doc (32 kb)
ESM 1 (DOC 31 kb)
198_2017_4059_MOESM2_ESM.docx (16 kb)
ESM 2 (DOCX 16 kb)
198_2017_4059_MOESM3_ESM.docx (14 kb)
ESM 3 (DOCX 13 kb)
198_2017_4059_MOESM4_ESM.tif (128 kb)
ESM 4 (TIFF 127 kb)

References

  1. 1.
    Feig DI, Kang D-H, Johnson RJ (2008) Uric acid and cardiovascular risk. N Engl J Med 359(17):1811–1821CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Kellogg EW, Fridovich I (1977) Liposome oxidation and erythrocyte lysis by enzymically generated superoxide and hydrogen peroxide. J Biol Chem 252(19):6721–6728PubMedGoogle Scholar
  3. 3.
    Proctor PH (2008) Uric acid and neuroprotection. Stroke 39(8):e126-eCrossRefGoogle Scholar
  4. 4.
    Waring SW, Webb DJ, Maxwell SR (2001) Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers. J Cardiovasc Pharmacol 38(3):365–371CrossRefPubMedGoogle Scholar
  5. 5.
    Bowman GL, Shannon J, Frei B, Kaye JA, Quinn JF (2010) Uric acid as a CNS antioxidant. Journal of Alzheimer’s disease : JAD 19(4):1331–1336CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Paganoni S, Zhang M, Quiroz Zarate A, Jaffa M, Yu H, Cudkowicz ME et al (2012) Uric acid levels predict survival in men with amyotrophic lateral sclerosis. J Neurol 259(9):1923–1928CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G (2009) Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med 266(6):558–570CrossRefPubMedGoogle Scholar
  8. 8.
    Oda E, Kawai R, Sukumaran V, Watanabe K (2009) Uric acid is positively associated with metabolic syndrome but negatively associated with diabetes in Japanese men. Internal medicine (Tokyo, Japan) 48(20):1785–1791CrossRefGoogle Scholar
  9. 9.
    Ames BN, Cathcart R, Schwiers E, Hochstein P (1981) Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A 78(11):6858–6862CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Sautin YY, Johnson RJ (2008) Uric acid: the oxidant-antioxidant paradox. Nucleosides, nucleotides & nucleic acids 27(6):608–619CrossRefGoogle Scholar
  11. 11.
    Landmesser U, Spiekermann S, Dikalov S, Tatge H, Wilke R, Kohler C et al (2002) Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation 106(24):3073–3078CrossRefPubMedGoogle Scholar
  12. 12.
    Feig DI, Kang DH, Johnson RJ (2008) Uric acid and cardiovascular risk. N Engl J Med 359(17):1811–1821CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Sanchez-Rodriguez MA, Ruiz-Ramos M, Correa-Munoz E, Mendoza-Nunez VM (2007) Oxidative stress as a risk factor for osteoporosis in elderly Mexicans as characterized by antioxidant enzymes. BMC Musculoskelet Disord 8:124CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Basu S, Michaelsson K, Olofsson H, Johansson S, Melhus H (2001) Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun 288(1):275–279CrossRefPubMedGoogle Scholar
  15. 15.
    Mody N, Parhami F, Sarafian TA, Demer LL (2001) Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 31(4):509–519CrossRefPubMedGoogle Scholar
  16. 16.
    Wauquier F, Leotoing L, Coxam V, Guicheux J, Wittrant Y (2009) Oxidative stress in bone remodelling and disease. Trends Mol Med 15(10):468–477CrossRefPubMedGoogle Scholar
  17. 17.
    Zhang D, Bobulescu IA, Maalouf NM, Adams-Huet B, Poindexter J, Park S et al (2015) Relationship between serum uric acid and bone mineral density in the general population and in rats with experimental hyperuricemia. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 30(6):992–999CrossRefGoogle Scholar
  18. 18.
    Ahn SH, Lee SH, Kim BJ, Lim KH, Bae SJ, Kim EH et al (2013) Higher serum uric acid is associated with higher bone mass, lower bone turnover, and lower prevalence of vertebral fracture in healthy postmenopausal women. Osteoporosis international. a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 24(12):2961–2970CrossRefGoogle Scholar
  19. 19.
    Nabipour I, Sambrook PN, Blyth FM, Janu MR, Waite LM, Naganathan V et al (2011) Serum uric acid is associated with bone health in older men: a cross-sectional population-based study. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 26(5):955–964CrossRefGoogle Scholar
  20. 20.
    Lane NE, Parimi N, Lui LY, Wise BL, Yao W, Lay YA et al (2014) Association of serum uric acid and incident nonspine fractures in elderly men: the Osteoporotic Fractures in Men (MrOS) study. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 29(7):1701–1707CrossRefGoogle Scholar
  21. 21.
    Kim BJ, Baek S, Ahn SH, Kim SH, Jo MW, Bae SJ et al (2014) Higher serum uric acid as a protective factor against incident osteoporotic fractures in Korean men: a longitudinal study using the National Claim Registry. Osteoporosis international. a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 25(7):1837–1844CrossRefGoogle Scholar
  22. 22.
    Muka T, de Jonge EA, de Jong JC, Uitterlinden AG, Hofman A, Dehghan A et al (2016) The influence of serum uric acid on bone mineral density, hip geometry, and fracture risk: the Rotterdam study. J Clin Endocrinol Metab 101(3):1113–1122CrossRefPubMedGoogle Scholar
  23. 23.
    Mehta T, Buzkova P, Sarnak MJ, Chonchol M, Cauley JA, Wallace E et al (2015) Serum urate levels and the risk of hip fractures: data from the Cardiovascular Health Study. Metab Clin Exp 64(3):438–446CrossRefPubMedGoogle Scholar
  24. 24.
    Veronese N, Bolzetta F, De Rui M, Maggi S, Noale M, Zambon S et al (2015) Serum uric acid and incident osteoporotic fractures in old people: the PRO.V.A study. Bone 79:183–189CrossRefPubMedGoogle Scholar
  25. 25.
    Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283(15):2008–2012CrossRefPubMedGoogle Scholar
  26. 26.
    Rodondi N, Aujesky D, Vittinghoff E, Cornuz J, Bauer DC (2006) Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis. Am J Med 119(7):541–551CrossRefPubMedGoogle Scholar
  27. 27.
    Egger M, Smith GD, Schneider M (2008) Systematic reviews of observational studies. Systematic reviews in health care. BMJ Publishing Group:211–227Google Scholar
  28. 28.
    Wirth CD, Blum MR, da Costa BR, Baumgartner C, Collet TH, Medici M et al (2014) Subclinical thyroid dysfunction and the risk for fractures: a systematic review and meta-analysis. Ann Intern Med 161(3):189–199CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC et al (2014) Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ (Clinical research ed) 348:g1903Google Scholar
  30. 30.
    Danesh J, Collins R, Appleby P, Peto R (1998) Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 279(18):1477–1482CrossRefPubMedGoogle Scholar
  31. 31.
    Chowdhury R, Warnakula S, Kunutsor S, Crowe F, Ward HA, Johnson L et al (2014) Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med 160(6):398–406CrossRefPubMedGoogle Scholar
  32. 32.
    DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188CrossRefPubMedGoogle Scholar
  33. 33.
    Lee JS, Buzkova P, Fink HA, Vu J, Carbone L, Chen Z et al (2010) Subclinical thyroid dysfunction and incident hip fracture in older adults. Arch Intern Med 170(21):1876–1883CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558CrossRefPubMedGoogle Scholar
  35. 35.
    Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed) 315(7109):629–634CrossRefGoogle Scholar
  36. 36.
    Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088–1101CrossRefPubMedGoogle Scholar
  37. 37.
    Makovey J, Macara M, Chen JS, Hayward CS, March L, Seibel MJ et al (2013) Serum uric acid plays a protective role for bone loss in peri- and postmenopausal women: a longitudinal study. Bone 52(1):400–406CrossRefPubMedGoogle Scholar
  38. 38.
    Dalbeth N, Gamble GD, Horne A, Reid IR (2016) Relationship between changes in serum urate and bone mineral density during treatment with thiazide diuretics: secondary analysis from a randomized controlled trial. Calcif Tissue Int 98(5):474–478CrossRefPubMedGoogle Scholar
  39. 39.
    Xiong A, Yao Q, He J, Fu W, Yu J, Zhang Z (2016) No causal effect of serum urate on bone-related outcomes among a population of postmenopausal women and elderly men of Chinese Han ethnicity-a Mendelian randomization study. Osteoporosis international. a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 27(3):1031–1039CrossRefGoogle Scholar
  40. 40.
    Dong XW, Tian HY, He J, Wang C, Qiu R, Chen YM (2016) Elevated serum uric acid is associated with greater bone mineral density and skeletal muscle mass in middle-aged and older adults. PLoS One 11(5):e0154692CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA (2005) Uric acid and oxidative stress. Curr Pharm Des 11(32):4145–4151CrossRefPubMedGoogle Scholar
  42. 42.
    Waring WS, Webb DJ, Maxwell SR (2001) Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers. J Cardiovasc Pharmacol 38(3):365–371CrossRefPubMedGoogle Scholar
  43. 43.
    Almeida M, Han L, Martin-Millan M, O’Brien CA, Manolagas SC (2007) Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor- to forkhead box O-mediated transcription. J Biol Chem 282(37):27298–27305CrossRefPubMedGoogle Scholar
  44. 44.
    Ostman B, Michaelsson K, Helmersson J, Byberg L, Gedeborg R, Melhus H et al (2009) Oxidative stress and bone mineral density in elderly men: antioxidant activity of alpha-tocopherol. Free Radic Biol Med 47(5):668–673CrossRefPubMedGoogle Scholar
  45. 45.
    Gao X, O’Reilly EJ, Schwarzschild MA, Ascherio A (2016) Prospective study of plasma urate and risk of Parkinson disease in men and women. Neurology 86(6):520–526CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Chen H, Mosley TH, Alonso A, Huang X (2009) Plasma urate and Parkinson’s disease in the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 169(9):1064–1069CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Khanna D, Khanna PP, Fitzgerald JD, Singh MK, Bae S, Neogi T et al (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis care & research 64(10):1447–1461CrossRefGoogle Scholar
  48. 48.
    Lems WF (2015) Fracture risk estimation may facilitate the treatment gap in osteoporosis. Ann Rheum Dis 74(11):1943–1945CrossRefPubMedGoogle Scholar
  49. 49.
    Altman DG (2001) Systematic reviews of evaluations of prognostic variables. BMJ (Clinical research ed) 323(7306):224–228CrossRefGoogle Scholar
  50. 50.
    Sterne JA, Egger M, Smith GD (2001) Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ (Clinical research ed) 323(7304):101–105CrossRefGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2017

Authors and Affiliations

  1. 1.Department of OrthopedicsChinese PLA General HospitalBeijingPeople’s Republic of China

Personalised recommendations